Lanean...
NTM drug discovery: status, gaps and the way forward
Incidence of pulmonary diseases caused by non-tuberculous mycobacteria (NTM), relatives of Mycobacterium tuberculosis, is increasing at an alarming rate, surpassing tuberculosis in many countries. Current chemotherapies require long treatment times and the clinical outcomes are often disappointing....
Gorde:
| Argitaratua izan da: | Drug Discov Today |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078814/ https://ncbi.nlm.nih.gov/pubmed/29635026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2018.04.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|